Crosslinking membrane
IgM receptors on a set of murine
B cell lymphomas leads to a rapid increase in c-myc, followed by a decrease in its expression to undetectable levels by 8-24 hours. These cells die soon thereafter via apoptosis.
IgD receptor crosslinking also leads to an increase in c-myc expression, but it remains above baseline levels for more than 24 hours; these cells continue to proliferate and do not die. We previously reported that
antisense oligonucleotides for c-myc prevented growth arrest and cell death in these
lymphomas, independent of the presence of mitogenic CpG motifs. Indeed, antisense for c-myc actually led to a stabilization of c-myc message and
protein. Growth arrest in these cells is dependent on the increased synthesis of the p27
cyclin kinase inhibitor (Kip1) normally induced after
anti-IgM crosslinking. Consistent with its
biologic effects,
anti-IgD does not cause an increase in p27. Since
dexamethasone causes a loss of myc and synergizes with the
anti-IgM signal, we suggest that accelerated cell death with this
steroid in the presence of
anti-IgM is due to a more rapid degradation of this
oncogene product. Finally, we propose that c-myc drives the transcription or activation of an inhibitor of the p27 Kip (Kipi). Hence, loss of c-myc in response to
anti-IgM signals in these
B-cell lymphomas leads to upregulation of p27, growth arrest and apoptosis. It follows that maintenance of c-myc in these
B-cell lymphomas should lead to survival and no increase in p27.